UK Markets open in 4 hrs 59 mins

Genomic Vision Société Anonyme (0QT4.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.0571-0.0249 (-30.37%)
At close: 05:23PM GMT
Full screen
Loading interactive chart…
  • Globe Newswire

    Genomic Vision’s cutting-edge TeloSizer® application to be used in cancer research

    GENOMICS | GENETICS | R&D | DIAGNOSIS TESTS Genomic Vision’s cutting-edge TeloSizer® application to be used in cancer research Genomic Vision and CNRS launch a core oncology program with the Cancer Research Center of Marseille to develop companion tests based on TeloSizer® Bagneux (France) – Genomic Vision (FR0011799907 – GV, the “Company”), a Euronext-listed biotechnology company that develops tools and services for the highly accurate characterization of DNA sequences, is pleased to announce a

  • Business Wire

    Genomic Vision and Cambridge Consultants, Part of Capgemini, Announce the Development of an Innovative Technology Platform for In-depth Genomic Analysis

    BAGNEUX, France & CAMBRIDGE, England, November 07, 2022--Regulatory News: Genomic Vision (FR0011799907 – GV, – the "Company") (Paris:GV), a Euronext-listed biotechnology company developing tools and services for the highly accurate characterization of DNA sequences, is pleased to announce the selection of Cambridge Consutants, a world-leading product development and technology consultancy, part of Capgemini Invent1, to jointly develop the next generation of a technology platform for the analysis

  • Business Wire

    Genomic Vision: Financial Information for the Third Quarter of 2022

    BAGNEUX, France, October 27, 2022--Regulatory News: Genomic Vision (FR0011799907 – GV, – the "Company") (Paris:GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announced its revenue and cash position for the nine-month ended on September 30, 2022.